logo
Tests 'closer to home' as new diagnostic centre opens in Hinckley

Tests 'closer to home' as new diagnostic centre opens in Hinckley

BBC News28-06-2025
A £24.6 million community diagnostic centre has opened in Hinckley.The Leicester, Leicestershire and Rutland Integrated Care Board (LLR ICB) says the centre is the first of it's kind in the county.The facility aims to offer patients a wide range of diagnostic tests closer to home, it says, to ease pressure on busy hospitals. Located next to the site of the former Hinckley and District Community Hospital in Mount Road, it will provide tests such as CT and MRI scans, X-rays and ultrasounds, phlebotomy, dermatology, audiology assessments and endoscopy.
The centre is expected to undertake 70,000 tests this year, increasing to more than 80,000 next year, the LLR ICB said.Ros Chadwin, 52, from Burbage in Leicestershire, said she was able to have an X-ray in her lunch break after the centre opened on Friday."I was able to nip out and have it done, and nip back.She added: "I've even got time to take the dog for a walk!"
Judith Spiers, head of nursing for community hospitals in Leicester, said: "The patients won't need to travel to the main hospitals, which takes pressure off the roads and the parking, but also it takes pressure off those sites so we can do the acute care there and the diagnostics can be done in centres like this."
Helen Hendley, director of planned care for LLR ICB, said: "It's going to make such a difference to the local area.""We have made such inroads with our long waits for patients across the patch, but we know if we can get our diagnostics tests in quicker, we can then get to a treatment plan faster too."
Officially opening the centre was Conservative MP for Hinckley and Bosworth, Dr Luke Evans. He said: "The next step is the £10 million day case unit over the road that we are working on, so that people can have their operations done here as well."The two centres would compliment each other perfectly."
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Hack at UnitedHealth's tech unit impacted 192.7 million people, US health dept website shows
Hack at UnitedHealth's tech unit impacted 192.7 million people, US health dept website shows

Reuters

time17 minutes ago

  • Reuters

Hack at UnitedHealth's tech unit impacted 192.7 million people, US health dept website shows

Aug 14 (Reuters) - The cyberattack at UnitedHealth Group's (UNH.N), opens new tab tech unit last year impacted 192.7 million people, the U.S. health department's website showed on Thursday. In January, the company had estimated the hack at Change Healthcare affected the personal information of 190 million people. The cyberattack — the largest healthcare data breach in the United States to date — was disclosed in February last year. The unit was infiltrated by hackers who identified themselves as the "Blackcat" ransomware group, causing widespread disruptions in claims processing and impacting patients and providers across the country. The number of impacted people was posted on a list of data breaches maintained by the U.S. Department of Health and Human Services' office for civil rights. UnitedHealth did not immediately respond to a Reuters request for comment. Information made vulnerable in the UnitedHealth attack is believed to include health insurance member IDs, patient diagnoses, treatment information and social security numbers, as well as billing codes used by providers.

Eli Lilly ramps up UK price of weight loss jab Mounjaro after Trump demands
Eli Lilly ramps up UK price of weight loss jab Mounjaro after Trump demands

The Guardian

timean hour ago

  • The Guardian

Eli Lilly ramps up UK price of weight loss jab Mounjaro after Trump demands

The price of the weight loss jab Mounjaro will rise by up to 170% in the UK, its US manufacturer has said, as Donald Trump ramps up pressure on drugmakers to increase their prices for Europeans so that they can make them more affordable for Americans. Eli Lilly has said it will increase the price of the drug from September, with a month's supply of the highest dose rising from £122 to £330. Mounjaro contains tirzepatide and is self-administered in once-a-week injections. When it launched in Britain in February 2024, Eli Lilly agreed to a list price 'significantly below' its other European markets to stop delays in availability of the medicine through the NHS. The increase in the list price will align it 'more consistently', the company said, although it added the NHS would not pay the new higher price to ensure continued access for the people with obesity and type 2 diabetes receiving it through the health service. Eli Lilly said it was working with private healthcare providers, which could negotiate their own confidential discounts with the company. Trump has threatened to use 'every tool in our arsenal' to crack down on pharmaceutical companies charging higher prices in the US compared with other nations. The US pays about three times more for drugs compared with other developed countries, according to the Rand Corporation thinktank. On 31 July, Trump sent letters to 17 of the world's biggest drugmakers, including Eli Lilly and Novo Nordisk, demanding cuts to drug prices for Americans within 60 days. 'Make no mistake: a collaborative effort towards achieving global pricing parity would be the most effective path for companies, the government and American patients,' Trump wrote. 'But if you refuse to step up we will deploy every tool in our arsenal to protect American families from continued abusive drug pricing practices. 'Americans are demanding lower drug prices, and they need them today.' In May, Trump told reporters that a friend in London had told him he had bought the 'fat shot drug' for $88, compared with $1,300 in New York. Pharmaceutical companies have cashed in on huge demand for weight loss treatments. Denmark's Novo Nordisk has become one of the most prominent names in the field, launching Wegovy in the UK in September 2023, turning it into one of the most valuable companies in Europe. While the jabs have increased profits at big pharmaceutical companies, they are racing to develop an equivalent pill, which would be a more convenient and cheaper alternative for patients and healthcare authorities. Eli Lilly said this month that a pill in early trial stages showed that participants on their highest dose lost an average of 12.4% of their body weight, compared with 0.9% of the control group. Novo Nordisk has submitted its oral weight loss drug for approval in the US. Its trial results showed that participants could lose about 15% of their body weight.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store